12.47 9.71 1.89 NP 411.61 9.87 392.03 9.52 19.58 4.99 EPS (Baht per Share) * 0.43 0.39 0.04 10.26 Weighted Average Number of Ordinary Shares (Million Shares) * 947.96 997.41 (49.45) (4.96) Return on
3,308.7 2,338.8 (969.9) (29.3%) 4,433.9 5,535.2 1,101.3 24.8% Normalized Net Profit/3 903.1 523.8 (379.3) (42.0%) 815.9 1,128.2 312.4 38.3% /1 Including other income and share of profit from investments in
3,308.7 2,338.8 (969.9) (29.3%) 4,433.9 5,535.2 1,101.3 24.8% Normalized Net Profit/3 903.1 523.8 (379.3) (42.0%) 815.9 1,128.2 312.4 38.3% /1 Including other income and share of profit from investments in
existing shareholder (the “Share Acquisition Transaction”). Share Acquisition Transaction is expected to be completed by October 31, 2017. Details of the Share Acquisition Transaction are as follows: 1
medical service concerning health and esthetics. 2. Overview of operating results in 3 quarters of 2019. Continued from the first Quarter of 2019 until third Quarter, the world economic still be tense from
sectors, which some part mainly comes from export and tourism sectors and internal expenditure rate has gradually expanded as well. These economic situations leaded to quarter 3/201 the Company gained
esthetics. 2. Overview of operating results in the Quarter 2’2019. Continued from the first Quarter of 2019 until second Quarter, the world economic still be tense from political crisis in many country and
service concerning health and esthetics. 2. Overview of operating results in the Quarter 2’2018. Although the global economy is at risk, such as political tensions and economic of international, or the
concerning health and esthetics. 2. Overview of operating results in the Quarter 3’2018. Although the global economy as risk from international of political tensions and economic, and the uncertainty of US
expenditure of governmental sector and consumer of private sector. Those economic conditions influence the previous Quarter / that the Group gained more revenue from product distribution and service business at